Composition of central and peripheral lymphatic organs
Cell populations . | WT . | Bmf−/− . | Bim−/− . | DKO . |
---|---|---|---|---|
Thymus* | ||||
Total (×107) | 23.28 ± 2.95 | 31.61 ± 0.90 | 28.95 ± 5.10 | 24.39 ± 2.46 |
CD4−8- | 0.71 ± 0.02 | 0.95 ± 0.10† | 2.85 ± 0.66†‡ | 2.36 ± 0.23†‡ |
CD4+8+ | 19.71 ± 3.78 | 27.5 ± 0.77 | 18.5 ± 2.98 | 16.34 ± 1.92‡ |
CD4+8- | 2.17 ± 0.29 | 2.20 ± 0.08 | 5.58 ± 1.15†‡ | 3.96 ± 0.46†‡ |
CD4−8+ | 0.70 ± 0.10 | 0.92 ± 0.06 | 1.54 ± 0.20†‡ | 1.74 ± 0.23†‡ |
Spleen | ||||
Total (×107) | 13.89 ± 0.87 | 21.21 ± 2.52† | 27.9 ± 4.64† | 41.64 ± 4.14†‡§ |
B cells | ||||
B220+ | 8.12 ± 0.88 | 14.5 ± 1.98† | 14.91 ± 2.21† | 26.45 ± 3.48†‡§ |
T1 | 0.95 ± 0.23 | 1.44 ± 0.3 | 1.85 ± 0.44 | 3.31 ± 0.58†‡ |
T2 | 0.93 ± 0.07 | 1.88 ± 0.3† | 1.98 ± 0.4† | 3.58 ± 0.38†‡§ |
FO | 5.19 ± 0.59 | 10.4 ± 1.54† | 9.87 ± 1.56† | 15.09 ± 1.76†§ |
MZ | 1.08 ± 0.16 | 1.53 ± 0.28 | 1.39 ± 0.25 | 2.35 ± 0.49† |
PC/PB | 1.37 ± 0.19 | 2.24 ± 0.35† | 3.97 ± 0.6† | 8.4 ± 1.24†‡§ |
T cells | ||||
TCRβ+ | 3.98 ± 0.39 | 4.62 ± 0.41 | 7.88 ± 1.39† | 8.04 ± 0.78†‡ |
Naïve CD4 | 1.42 ± 0.19 | 1.48 ± 0.09 | 1.84 ± 0.49 | 1.38 ± 0.2 |
TCM CD4 | 0.51 ± 0.11 | 0.56 ± 0.13 | 1.12 ± 0.32 | 1.14 ± 0.26 |
TEM CD4 | 0.41 ± 0.03 | 0.63 ± 0.12 | 1.05 ± 0.22† | 1.06 ± 0.18† |
Naïve CD8 | 0.78 ± 0.13 | 0.87 ± 0.18 | 1.3 ± 0.36 | 1.34 ± 0.2 |
TCM CD8 | 0.46 ± 0.06 | 0.51 ± 0.11 | 1.01 ± 0.18† | 1.13 ± 0.18†‡ |
TEM CD8 | 0.24 ± 0.06 | 0.39 ± 0.15 | 0.63 ± 0.12† | 0.86 ± 0.19† |
Ratio CD4/CD8 | 1.66 ± 0.08 | 1.54 ± 0.09 | 1.39 ± 0.08† | 1.13 ± 0.06†‡§ |
Ratio B220/TCRβ | 2.06 ± 0.16 | 3.12 ± 0.25† | 1.96 ± 0.1‡ | 3.27 ± 0.22†§ |
Myeloid cells | ||||
Granulocytes | 0.087 ± 0.02 | 0.16 ± 0.06 | 0.08 ± 0.03 | 0.12 ± 0.01 |
Monocytes | 0.28 ± 0.1 | 0.4 ± 0.15 | 0.53 ± 0.17 | 0.56 ± 0.21 |
Ter119+ | 0.99 ± 0.15 | 2.46 ± 0.56† | 4.07 ± 1.05† | 5.43 ± 1.07†‡ |
Bone marrow | ||||
Total (×106) | 33.45 ± 4.76 | 36.44 ± 6.77 | 29.45 ± 4.71 | 35.03 ± 4.06 |
B cells | ||||
B220+ | 8.7 ± 1.28 | 9.87 ± 1.46 | 10.06 ± 1.59 | 14.49 ± 1.73† |
Pro-B cells | 0.71 ± 0.1 | 0.73 ± 0.14 | 0.92 ± 0.19 | 1.02 ± 0.08† |
Pre-B cells | 4.62 ± 0.61 | 5.74 ± 1.13 | 4.27 ± 0.85 | 5.08 ± 0.94 |
IM B cells | 2.41 ± 0.58 | 2.52 ± 0.42 | 2.7 ± 0.51 | 3.63 ± 0.77 |
M B cells | 2.15 ± 0.31 | 3.21 ± 0.79 | 4 ± 0.73† | 7.63 ± 1.08†‡§ |
Percentage small pre-B | 65.14 ± 4.35 | 67.88 ± 1.93 | 71.65 ± 2.45 | 80.07 ± 3.87†‡ |
Myeloid cells | ||||
Granulocytes | 6.17 ± 0.77 | 6.76 ± 0.99 | 4.17 ± 0.66 | 3.65 ± 0.62†‡ |
Monocytes | 3.36 ± 0.45 | 3.44 ± 0.54 | 3 ± 0.48 | 3.03 ± 0.85 |
Ter119+ | 6.96 ± 1.56 | 9.56 ± 2.82 | 6.32 ± 1.71 | 7.05 ± 1.63 |
PBL | ||||
WBC/μL¶ | 7116 ± 808 | 15 180 ± 2 446† | 27 557 ± 4 016†‡ | 33 725 ± 4 938†‡ |
B220+ | 4867 ± 796 | 11 959 ± 2 020† | 21 207 ± 3 543†‡ | 25 577 ± 4 358†‡ |
CD4+ | 742 ± 248 | 920 ± 263 | 1 808 ± 573 | 1 338 ± 365 |
CD8+ | 564 ± 145 | 908 ± 221 | 2 308 ± 606† | 1 780 ± 307† |
Monocytes | 564 ± 166 | 855 ± 180 | 1 201 ± 354 | 2 494 ± 1007 |
Granulocytes | 621 ± 108 | 684 ± 139 | 709 ± 123 | 1 784 ± 383†§ |
Cell populations . | WT . | Bmf−/− . | Bim−/− . | DKO . |
---|---|---|---|---|
Thymus* | ||||
Total (×107) | 23.28 ± 2.95 | 31.61 ± 0.90 | 28.95 ± 5.10 | 24.39 ± 2.46 |
CD4−8- | 0.71 ± 0.02 | 0.95 ± 0.10† | 2.85 ± 0.66†‡ | 2.36 ± 0.23†‡ |
CD4+8+ | 19.71 ± 3.78 | 27.5 ± 0.77 | 18.5 ± 2.98 | 16.34 ± 1.92‡ |
CD4+8- | 2.17 ± 0.29 | 2.20 ± 0.08 | 5.58 ± 1.15†‡ | 3.96 ± 0.46†‡ |
CD4−8+ | 0.70 ± 0.10 | 0.92 ± 0.06 | 1.54 ± 0.20†‡ | 1.74 ± 0.23†‡ |
Spleen | ||||
Total (×107) | 13.89 ± 0.87 | 21.21 ± 2.52† | 27.9 ± 4.64† | 41.64 ± 4.14†‡§ |
B cells | ||||
B220+ | 8.12 ± 0.88 | 14.5 ± 1.98† | 14.91 ± 2.21† | 26.45 ± 3.48†‡§ |
T1 | 0.95 ± 0.23 | 1.44 ± 0.3 | 1.85 ± 0.44 | 3.31 ± 0.58†‡ |
T2 | 0.93 ± 0.07 | 1.88 ± 0.3† | 1.98 ± 0.4† | 3.58 ± 0.38†‡§ |
FO | 5.19 ± 0.59 | 10.4 ± 1.54† | 9.87 ± 1.56† | 15.09 ± 1.76†§ |
MZ | 1.08 ± 0.16 | 1.53 ± 0.28 | 1.39 ± 0.25 | 2.35 ± 0.49† |
PC/PB | 1.37 ± 0.19 | 2.24 ± 0.35† | 3.97 ± 0.6† | 8.4 ± 1.24†‡§ |
T cells | ||||
TCRβ+ | 3.98 ± 0.39 | 4.62 ± 0.41 | 7.88 ± 1.39† | 8.04 ± 0.78†‡ |
Naïve CD4 | 1.42 ± 0.19 | 1.48 ± 0.09 | 1.84 ± 0.49 | 1.38 ± 0.2 |
TCM CD4 | 0.51 ± 0.11 | 0.56 ± 0.13 | 1.12 ± 0.32 | 1.14 ± 0.26 |
TEM CD4 | 0.41 ± 0.03 | 0.63 ± 0.12 | 1.05 ± 0.22† | 1.06 ± 0.18† |
Naïve CD8 | 0.78 ± 0.13 | 0.87 ± 0.18 | 1.3 ± 0.36 | 1.34 ± 0.2 |
TCM CD8 | 0.46 ± 0.06 | 0.51 ± 0.11 | 1.01 ± 0.18† | 1.13 ± 0.18†‡ |
TEM CD8 | 0.24 ± 0.06 | 0.39 ± 0.15 | 0.63 ± 0.12† | 0.86 ± 0.19† |
Ratio CD4/CD8 | 1.66 ± 0.08 | 1.54 ± 0.09 | 1.39 ± 0.08† | 1.13 ± 0.06†‡§ |
Ratio B220/TCRβ | 2.06 ± 0.16 | 3.12 ± 0.25† | 1.96 ± 0.1‡ | 3.27 ± 0.22†§ |
Myeloid cells | ||||
Granulocytes | 0.087 ± 0.02 | 0.16 ± 0.06 | 0.08 ± 0.03 | 0.12 ± 0.01 |
Monocytes | 0.28 ± 0.1 | 0.4 ± 0.15 | 0.53 ± 0.17 | 0.56 ± 0.21 |
Ter119+ | 0.99 ± 0.15 | 2.46 ± 0.56† | 4.07 ± 1.05† | 5.43 ± 1.07†‡ |
Bone marrow | ||||
Total (×106) | 33.45 ± 4.76 | 36.44 ± 6.77 | 29.45 ± 4.71 | 35.03 ± 4.06 |
B cells | ||||
B220+ | 8.7 ± 1.28 | 9.87 ± 1.46 | 10.06 ± 1.59 | 14.49 ± 1.73† |
Pro-B cells | 0.71 ± 0.1 | 0.73 ± 0.14 | 0.92 ± 0.19 | 1.02 ± 0.08† |
Pre-B cells | 4.62 ± 0.61 | 5.74 ± 1.13 | 4.27 ± 0.85 | 5.08 ± 0.94 |
IM B cells | 2.41 ± 0.58 | 2.52 ± 0.42 | 2.7 ± 0.51 | 3.63 ± 0.77 |
M B cells | 2.15 ± 0.31 | 3.21 ± 0.79 | 4 ± 0.73† | 7.63 ± 1.08†‡§ |
Percentage small pre-B | 65.14 ± 4.35 | 67.88 ± 1.93 | 71.65 ± 2.45 | 80.07 ± 3.87†‡ |
Myeloid cells | ||||
Granulocytes | 6.17 ± 0.77 | 6.76 ± 0.99 | 4.17 ± 0.66 | 3.65 ± 0.62†‡ |
Monocytes | 3.36 ± 0.45 | 3.44 ± 0.54 | 3 ± 0.48 | 3.03 ± 0.85 |
Ter119+ | 6.96 ± 1.56 | 9.56 ± 2.82 | 6.32 ± 1.71 | 7.05 ± 1.63 |
PBL | ||||
WBC/μL¶ | 7116 ± 808 | 15 180 ± 2 446† | 27 557 ± 4 016†‡ | 33 725 ± 4 938†‡ |
B220+ | 4867 ± 796 | 11 959 ± 2 020† | 21 207 ± 3 543†‡ | 25 577 ± 4 358†‡ |
CD4+ | 742 ± 248 | 920 ± 263 | 1 808 ± 573 | 1 338 ± 365 |
CD8+ | 564 ± 145 | 908 ± 221 | 2 308 ± 606† | 1 780 ± 307† |
Monocytes | 564 ± 166 | 855 ± 180 | 1 201 ± 354 | 2 494 ± 1007 |
Granulocytes | 621 ± 108 | 684 ± 139 | 709 ± 123 | 1 784 ± 383†§ |
Total numbers of hemopoietic cells from 6- to 8-week-old animals were calculated by counting single-cell suspensions derived from the indicated tissues. Cells were subsequently analyzed by flow cytometry after staining for cell surface markers: T1 B cells (B220+sIgMhighCD21low), T2 B cells (B220+sIgMhighCD21high), FO B cells (B220+CD21+CD23+), MZ B cells (B220+CD21+CD23−), PC/PBs (B220+/lowCD138+), naïve CD4+ or CD8+ T cells (CD62LhighCD44low), effector/memory (TEM) CD4+ or CD8+ T cells (CD62LlowCD44high), central memory (TCM) CD4+ or CD8+ T cells (CD62LhighCD44high), granulocytes (Gr-1+CD11b+), monocytes (Gr-1−CD11b+), pro-B cells (B220lowIgM−CD43+), pre-B cells (B220lowIgM−CD43−), immature (IM) B cells (B220lowIgM+), and mature (M) B cells (B220highIgM+). Numbers represent the mean ± standard error of the mean (SEM) of 5 to 8 mice per genotype. Total cellularity of both femora is presented.
Only female animals were analyzed.
P < .05 compared with WT mice.
P < .05 compared with Bmf−/− mice.
P < .05 compared with Bim−/− mice.
Cell number assessed in a Vet-ABC blood sample analyzer.